Cooperation of IRAK1/4 inhibitor and ABT-737 in nanoparticles for synergistic therapy of T cell acute lymphoblastic leukemia

References

• ChiarettiSFoaRT-cell acute lymphoblastic leukemiaHaematologica200994216016219181788
   PubMedGoogle Scholar
• DoresGMDevesaSSCurtisRELinetMSMortonLMAcute leukemia incidence and patient survival among children and adults in the United States, 2001–2007Blood20121191344322086414
   PubMed Web of Science ®Google Scholar
• PuiCHT cell acute lymphoblastic leukemia: NOTCHing the way toward a better treatment outcomeCancer Cell2009152858719185842
   PubMedGoogle Scholar
• JannePAGrayNSettlemanJFactors underlying sensitivity of cancers to small-molecule kinase inhibitorsNat Rev Drug Discov20098970972319629074
   PubMed Web of Science ®Google Scholar
• LiZYoungerKGartenhausRInhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapiesJ Clin Invest201512531081109725642772
   PubMedGoogle Scholar
• ChengHAddonaTKeshishianHRegulation of IRAK-4 kinase activity via autophosphorylation within its activation loopBiochem Biophys Res Commun2007352360961617141195
   PubMedGoogle Scholar
• KolleweCMackensenACNeumannDSequential autophosphorylation steps in the interleukin-1 receptor-associated kinase-1 regulate its availability as an adapter in interleukin-1 signalingJ Biol Chem200427975227523614625308
   PubMed Web of Science ®Google Scholar
• GelmanAEZhangJChoiYTurkaLAToll-like receptor ligands directly promote activated CD4+ T cell survivalJ Immunol2004172106065607315128790
   PubMed Web of Science ®Google Scholar
• ZhengLAsproditesNKeeneAHRodriguezPBrownKDDavilaETLR9 engagement on CD4 T lymphocytes represses gamma-radiation-induced apoptosis through activation of checkpoint kinase response elementsBlood200811152704271318086870
   PubMed Web of Science ®Google Scholar
• AkiraSHemmiHRecognition of pathogen-associated molecular patterns by TLR familyImmunol Lett2003852859512527213
   PubMed Web of Science ®Google Scholar
• KonoplevaMMilellaMRuvoloPMEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complexLeukemia201226477878722064351
   PubMed Web of Science ®Google Scholar
• Del Gaizo MooreVSchlisKDSallanSEArmstrongSALetaiABCL-2 dependence and ABT-737 sensitivity in acute lymphoblastic leukemiaBlood200811142300230918056841
   PubMedGoogle Scholar
• MatsumuraYMaedaHA new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancsCancer Res19864612 Pt 1638763922946403
   PubMed Web of Science ®Google Scholar
• PeerDKarpJMHongSFarokhzadOCMargalitRLangerRNanocarriers as an emerging platform for cancer therapyNat Nanotechnol200721275176018654426
   PubMed Web of Science ®Google Scholar
• DavisMEChenZGShinDMNanoparticle therapeutics: an emerging treatment modality for cancerNat Rev Drug Discov20087977178218758474
   PubMed Web of Science ®Google Scholar
• HuCMAryalSZhangLNanoparticle-assisted combination therapies for effective cancer treatmentTher Deliv20101232333422816135
   PubMedGoogle Scholar
• LivneyYDAssarafYGRationally designed nanovehicles to over-come cancer chemoresistanceAdv Drug Deliv Rev20136513–141716173023954781
   PubMed Web of Science ®Google Scholar
• SahooSKMaWLabhasetwarVEfficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancerInt J Cancer2004112233534015352049
   PubMed Web of Science ®Google Scholar
• YeWLZhaoYPLiHQDoxorubicin-poly (ethylene glycol)-alendronate self-assembled micelles for targeted therapy of bone metastatic cancerSci Rep201551461426419507
   PubMed Web of Science ®Google Scholar
• PalamakulaANutanMTKhanMAResponse surface methodology for optimization and characterization of limonene-based coenzyme Q10 self-nanoemulsified capsule dosage formAAPS PharmSciTech200454e6615760063
   PubMedGoogle Scholar
• ShaikhJAnkolaDDBeniwalVSinghDKumarMNNanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancerEur J Pharm Sci2009373–422323019491009
   PubMed Web of Science ®Google Scholar
• KrzekJKaletaJHubickaUNiedzwiedzAReversed-phase high-performance liquid chromatography determination of selected phenolic acids in propolis concentrates in terms of standardization for drug manufacturing purposesJ AOAC Int200689235235816640283
   PubMedGoogle Scholar
• AcharyaSDilnawazFSahooSKTargeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapyBiomaterials200930295737575019631377
   PubMed Web of Science ®Google Scholar
• MisraRSahooSKIntracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapyEur J Pharm Sci2010391–315216319961929
   PubMed Web of Science ®Google Scholar
• DilnawazFSinghAMohantyCSahooSKDual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapyBiomaterials201031133694370620144478
   PubMed Web of Science ®Google Scholar
• KabaraECoussensPMInfection of primary bovine macrophages with Mycobacterium avium subspecies paratuberculosis suppresses host cell apoptosisFront Microbiol2012203215
   Google Scholar
• LiuKFangRLiHEfficient derivation of embryonic stem cells from NOD-scid Il2rg (-/-) miceProtein Cell201561291691826404032
   PubMedGoogle Scholar
• JacobyEChienCDFryTJMurine models of acute leukemia: important tools in current pediatric leukemia researchFront Oncol201449524847444
   PubMedGoogle Scholar
• YangTYaoSZhangXGuoYAndrographolide inhibits growth of human T-cell acute lymphoblastic leukemia Jurkat cells by downregulation of PI3K/AKT and upregulation of p38 MAPK pathwaysDrug Des Devel Ther20161013891397
   PubMed Web of Science ®Google Scholar
• KitaKDittrichCDrug delivery vehicles with improved encapsulation efficiency: taking advantage of specific drug-carrier interactionsExpert Opin Drug Deliv20118332934221323506
   PubMed Web of Science ®Google Scholar
• Jaafar-MaalejCDiabRAndrieuVElaissariAFessiHEthanol injection method for hydrophilic and lipophilic drug-loaded liposome preparationJ Liposome Res201020322824319899957
   PubMed Web of Science ®Google Scholar
• PrakashPKulkarniPPChauhanAKThrombospondin 1 requires von Willebrand factor to modulate arterial thrombosis in miceBlood2015125239940625343959
   PubMedGoogle Scholar
• KempJAShimMSHeoCYKwonYJ“Combo” nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapyAdv Drug Deliv Rev20169831826546465
   PubMed Web of Science ®Google Scholar
• CaoLPanDLiDRelation between anti-atherosclerotic effects of IRAK4 and modulation of vascular smooth muscle cell phenotype in diabetic ratsAm J Transl Res20168289991027158377
   PubMedGoogle Scholar
• BaranskiZde JongYIlkovaTPharmacological inhibition of Bcl-xL sensitizes osteosarcoma to doxorubicinOncotarget2015634361133612526416351
   PubMedGoogle Scholar
• NiiTIshiiFEncapsulation efficiency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle methodInt J Pharm2005298119820515951143
   PubMed Web of Science ®Google Scholar